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Abstract
 
Regulation of immune system is of paramount importance to prevent immune attacks against
self-components. Mice deficient in the interleukin (IL)-2/IL-15 receptor 
 
 
 
 chain, CD122, are
model animals of such immune attacks and characteristically have a high number of abnormally
activated T cells. Here, we show that the transfer of CD8
 
 
 
CD122
 
 
 
 cells into CD122-deficient
neonates totally prevented the development of abnormal T cells. Furthermore, recombination
activating gene–2
 
   
 
 
 
mice that received wild-type mice–derived CD8
 
 
 
CD122
 
 
 
 cells died
within 10 wk after cell transfer, indicating that normal CD8
 
 
 
CD122
 
 
 
 cells become danger-
ously activated T cells in the absence of CD8
 
 
 
CD122
 
 
 
 T cells. CD8
 
 
 
CD122
 
 
 
 cells could
control activated CD8
 
 
 
 or CD4
 
 
 
 T cells both in vivo and in vitro. Our results indicate that the
CD8
 
 
 
CD122
 
 
 
 population includes naturally occurring CD8
 
 
 
 regulatory T cells that control
potentially dangerous T cells.
Key words: immune regulation • CD8
 
 
 
 T cells • CD122 • T cell control • activated T cells
 
Introduction
 
Immune reaction against virulent foreign objects could be
harmful for self-organisms. Therefore, a strict regulatory
mechanism must exist in the immune system (1–6). Regu-
latory T cells are key subpopulations of T cells that control
immune activity. CD4
 
 
 
CD25
 
 
 
 (IL-2 receptor 
 
 
 
 chain)
regulatory T cells are a well-documented subpopulation of
T cells (1, 2, 7–9). The importance of CD4
 
 
 
CD25
 
 
 
 regu-
latory T cells has been confirmed in many types of autoim-
mune diseases. However, other cells, especially those of
CD8
 
 
 
 T cell lineage, have also been suggested as regulatory
T cells (5, 10, 11).
CD122 (IL-2/IL-15 receptor 
 
 
 
 chain)-deficient mice
exhibit severe hyperimmunity (12) with augmented granu-
lopoiesis and suppressed erythropoiesis. Severe anemia pro-
gresses, and the mice die within 3–4 mo after birth. We
found that expansion of abnormally activated T cells is the
underlying cause of all phenotypes (13). The mechanism of
generation of activated memory-type T cells in CD122-
deficient mice is controversial. In the initial investigations
by Abbas and others (14–16), the defect of programmed
cell death (apoptosis) in IL-2 or IL-2R
 
 
 
–deficient T cells
could be applied to the mechanism for survival of activated
CD122-deficient T cells, and such a possibility has not
been excluded. Based on our previous experimental results,
we proposed that the lack of certain regulatory cells was re-
sponsible for the abnormal phenotypes and that a subpopu-
lation of CD8
 
 
 
 T cells could be involved in the control of
CD122-deficient abnormal T cells (11). However, in our
previous paper, direct evidence of the responsible subpopula-
tion in CD8
 
 
 
 cells was not provided, and it was still unclear
whether the lack of regulatory system is sufficient to cause
T cell abnormalities in CD122-deficient mice, or whether
intrinsic defect of CD122 molecules in T cells is required.
Here, we report a novel observation that the transfer of
highly purified CD8
 
 
 
CD122
 
 
 
 T cells from normal mice
into CD122-deficient neonates resulted in normalization of
all the phenotypes in these mice. This result indicates that
the CD8
 
 
 
CD122
 
 
 
 T cell population contains novel regu-
latory T cells that effectively control CD122-deficient T
cells. In addition, we show that RAG-2
 
   
 
 mice that re-
ceived wild-type mice–derived CD8
 
 
 
CD122
 
 
 
 cells die
within 10 wk after cell transfer, indicating that normal
CD8
 
 
 
CD122
 
 
 
 cells without intrinsic defect of CD122
molecules become dangerously activated T cells in the absence
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 HPRT, hypoxanthine-guanine phosphoribo-
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of CD8
 
 
 
CD122
 
 
 
 T cells, which control not only CD122-
deficient T cells but also wild-type T cells.
 
Materials and Methods
 
Mice. 
 
CD122-deficient mice were originally established by
Suzuki et al. (12) and maintained in our animal facility. Breeding
pairs of the C57BL/6
 
CD45.1/CD45.1
 
 congenic strain were obtained
from Taconic and maintained in our animal facility. RAG-2–
deficient mice with C57BL/6 genetic background were obtained
from The Central Institute for Experimental Animals with per-
mission from the founder F.W. Alt (Harvard Medical School)
and maintained in our animal facility. OT-I transgenic mice bear-
ing H-2K
 
b
 
-restricted OVA-specific TCR (17) were gifts from T.
Hirano and M. Murakami (Osaka University, Suita, Japan) The
experimental protocol was approved by the Ethics Review Com-
mittee for Animal Experimentation of Nagoya University Gradu-
ate School of Medicine.
 
T Cell Clones. 
 
OVA-specific helper-type T cell clones, 35-
9D and 35-8H, were gifts from T. Kato and K. Kuribayashi (Mie
University School of Medicine, Tsu, Japan; reference 18, 19).
 
Antibodies. 
 
FITC-conjugated anti–mouse CD8
 
 
 
 (clone 53-
6.7), PE-, or allophycocyanin-conjugated anti–mouse CD4 (clone
GK1.5); biotin-conjugated anti–mouse CD122 (clone 5H4); FITC-
conjugated anti–mouse CD25 (clone PC61.5); FITC- or biotin-
conjugated anti–mouse CD45.1 (clone A20); and biotin-conju-
gated anti–mouse TER-119 (clone TER-119) antibodies were
purchased from eBioscience. FITC-conjugated anti–mouse CD69
(clone H1.2F3), FITC-conjugated anti–mouse CD44 (clone IM7),
PE-conjugated anti–mouse CD62L (clone MEL-14), FITC-con-
jugated anti–mouse Gr-1 (clone RB6-8C5), and PE-conjugated
anti–mouse VLA-4 (clone 9C10) antibodies were purchased from
BD Biosciences. Biotin-conjugated antibodies were visualized by
streptavidin-PE-Cy5 (eBioscience).
 
Flow Cytometry and Cell Sorting. 
 
Analytical flow cytometry
was performed using FACS Calibur flow cytometer (BD Bio-
sciences). Preparative cell sorting was performed using FACS
Vantage cell sorter (BD Biosciences).
 
Adoptive T Cell Transfer to Neonates. 
 
T cells were hypoder-
mically transferred into 2–3-d-old neonates offspring of CD122-
heterozygous mutant parents. After the neonates grew beyond 3
wk, their genotype for CD122 gene was analyzed by PCR from
tail DNA (11).
 
Adoptive T Cell Transfer to RAG-2
 
   
 
 Mice.
 
T cells were in-
travenously transferred into 8–10-wk-old RAG-2–deficient mice
that had received a sublethal dose (5.5 Gy) of irradiation.
 
Hematocrit. 
 
Peripheral blood was taken from mice tail vein
using heparin-coated capillary tubes. After one end of the capil-
lary was sealed with clay, it was centrifuged, and the length of
packed RBC per total blood was measured.
 
Intracellular Cytokine Staining.
 
Intracellular cytokine staining
was performed using a Cytofix/Cytoperm kit (BD Biosciences)
according to the protocol provided by the manufacturer. Cells
were incubated with biotin-conjugated anti–IFN-
 
 
 
 or anti–IL-2
antibody and visualized with streptavidin-PE-Cy5.
 
Real-Time RT-PCR. 
 
Total cellular RNA was extracted by
using RNA-bee reagent (Tel-Test Inc.). The total amount of
RNA was reverse transcribed using Superscript II reverse-
transcriptase and random hexamer primers (Invitrogen). IFN-
 
 
 
,
TNF-
 
 
 
, and hypoxanthine-guanine phosphoribosyltransferase
(HPRT) mRNA levels were quantified by real-time PCR using
the ABI/PRISM 7700 sequence detection system (Applied Bio-
systems). Analyses were performed using primers, an internal flu-
orescent TaqMan probe specific to IFN-
 
 
 
, TNF-
 
 
 
, or HPRT,
and the TaqMan Universal PCR Master Mix (Applied Biosys-
tems). Premixture of primers and TaqMan probe of IFN-
 
 
 
 and
TNF-
 
 
 
 were optimized for real-time PCR system by the manu-
facturers. Standard curves of cDNA from total CD8
 
 
 
 T cells and
CD8
 
 
 
CD122
 
 
 
 T cells were used to calibrate the threshold cycle
to relative quantities of HPRT, TNF-
 
 
 
, and IFN-
 
 
 
 cDNA.
 
Results
 
Age-related Distribution of CD8
 
 
 
CD122
 
 
 
 Cells in Wild-
Type Mice.
 
In our previous paper, we found that the lack
of regulatory T cells is the cause of abnormal phenotype in
CD122-deficient mice (11). In the experiment of transfer of
a mixture of wild-type T cells and CD122-deficient T cells,
wild-type CD8
 
 
 
 T cells more effectively suppressed the ab-
normal activation of CD122-deficient T cells than wild-type
CD4
 
 
 
 T cells (11). Based on this observation, we hypothe-
sized that the regulatory T cells that control CD122
 
 
 
 cells
Figure 1. CD122  cells are more abundant in CD8  T cells than in
CD4  T cells in wild-type mice spleen. (a) Spleen cells were obtained from
7-wk-old wild-type C57BL/6 mice, stained with indicated fluorescence-
conjugated antibodies, and analyzed by flow cytometry. Percentages of
CD122  or CD25  cells in CD8  or in CD4  T cells are shown in each
panel. (b) Spleen cells were taken from mice of various ages, and the per-
centages of CD122  cells in CD8  cells were analyzed as in a. Data are
averages of two mice at each age. (right) Representative results of flow
cytometric analysis obtained from a 1-wk-old mouse, which shows
 50% of CD122  cells in the CD8  population, and that obtained from
a 6-wk-old mouse. 
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are in the CD8
 
 
 
 T cell population. Spleens (Fig. 1 a) and
lymph nodes (not depicted) contain CD122
 
 
 
 cells in the
CD8
 
 
 
 population. Because the expression level of CD122
fluctuates continuously among T cells both in CD8
 
 
 
 and
CD4
 
 
 
, it may be difficult to distinguish CD122
 
 
 
 from
CD122
 
 
 
. However, a population in CD8
 
 
 
 cells expresses
obviously high levels of CD122, the same expression level of
which is not observed in CD4
 
 
 
 T cells (Fig. 1 a). Therefore,
though some CD4
 
 
 
 cells are actually CD122
 
low
 
 
 
, we call
the cells forming a population with a high CD122 expres-
sion level CD122
 
 
 
 cells. The percentage of CD122
 
 
 
 cells in
the CD8
 
 
 
 population varied between 10 and 50% depend-
ing on mouse age (Fig. 1 b). Generally, the percentage of
CD122
 
 
 
 cells in CD8
 
 
 
 population was high in very young
mice, decreased to the lowest level of 
 
 
 
10% at 7–10 wk of
age, and increased in older mice. In contrast with the con-
siderable proportion of CD122
 
 
 
 cells in the CD8
 
 
 
 popula-
tion, CD122
 
 
 
 cells were rare in CD4
 
 
 
 population (Fig. 1 a,
top) although CD4
 
 
 
 cells contain CD122
 
low
 
 
 
 cells, many of
which are CD25
 
 
 
 (not depicted). This is in contrast with
the fact that CD25
 
 
 
 cells exist in the CD4
 
 
 
 population but
not in the CD8
 
 
 
 population (Fig. 1 a, bottom).
 
Isolation of CD8
 
 CD122  Cells and Their Transfer to
CD122-deficient Neonates.  CD8 CD122 , CD8 CD122 ,
and CD4 CD25  cells were isolated from spleens and
lymph nodes of 6-wk-old CD45.1 congeneic C57BL/6
mice by cell sorting. Fig. 2 a demonstrates that the purity of
specific cell population after cell sorting was  98%. Next,
5   104 of these highly purified cells were subcutaneously
transferred into CD122-deficient neonates, and the cells
obtained from spleens or lymph nodes were analyzed 7 wk
later. No donor-type CD4  T cells were observed at 7 wk
after transfer of CD8  T cells, indicating that phenotypic
changes, if any, should not be due to contaminated CD4 
T cells (Fig. 2 b). Donor-type CD8  T cells were also very
few in CD4  T cell–transferred mice (Fig. 2 b). Analysis of
the absolute numbers of each T cell population, derived ei-
ther from host CD122-deficient mice or transferred wild-
type donor cells, showed that transferred donor-type cells,
especially CD8  cells, expanded  20 times (from 5   104
to  106) during the 7 wk (Fig. 2 c). Furthermore, anal-
ysis of CD122-deficient neonates after transfer of 104
CD8 CD122  cells derived from 2-wk-old or 2-yr-old
mice showed that the resultant donor-type T cells 7 wk af-
Figure 2. Highly purified T cell subpopulation and successful adoptive transfer to CD122-deficient neonates. (a) Spleen cells obtained from 6-wk-old
CD45.1 congeneic C57BL/6 mice were stained with anti-CD8 antibody and anti-CD122 antibody, or were stained with anti-CD25 antibody and anti-
CD4 antibody. CD8 CD122  T cells, CD8 CD122  T cells, and CD4 CD25  cells were collected by using a cell sorter, and recovered cells were
analyzed by flow cytometry. Percentages of purity for required cells are shown in each panel. (b) 5   104 each of purified CD8 CD122 ,
CD8 CD122 , or CD4 CD25  T cells were transferred into 2–3-d-old CD122-deficient neonates. 7 wk later, spleen cells were stained with the indi-
cated antibodies and analyzed by flow cytometry. Numbers in each quadrant indicate percentages of cells. (c) Absolute numbers of each T cell subpopu-
lation derived from host CD122-deficient mice and donor wild-type mice (H8: host-derived CD8  cells; D8: donor-derived CD8  cells; H4: host-
derived CD4  cells; and D4: host-derived CD4  cells). Absolute numbers of each T cell subpopulation were calculated by (absolute number of spleen
cells)   (percentage of T cell subpopulation determined by FACS analysis). Data are mean   SD values of three mice in each group. (d) 104 each of
purified CD8 CD122  T cells obtained from 2-wk-old or 2-yr-old CD45.1 congeneic C57BL/6 mice were transferred into 2–3-d-old CD122-deficient
neonates. 7 wk later, spleen cells were analyzed. Absolute numbers of each T cell subpopulation derived from host mice and donor mice are shown. Data
are mean   SD values of three mice in each group.CD8 CD122  Regulatory T Cells Control Other T Cells 1126
ter transfer were mostly CD8  cells and had expanded  50
times (from 104 to  106) during the 7 wk (Fig. 2 d).
CD8 CD122  Cells Prevent Expansion of CD122-defi-
cient Activated T Cells.  As shown in Fig. 3 (a and c, top
middle), CD122-deficient mice without any treatment had
a high percentage of activated memory-type T cells with
markers of CD69 , CD44 , and CD62L . In contrast,
CD122-deficient neonatal mice that received 5   104
CD8 CD122  cells showed no such increase of activated
CD69  T cells (Fig. 3 a, bottom left) and CD44 CD62L 
activated memory-type T cells (Fig. 3 c, bottom left).
Transfer of 5   104 CD8 CD122  T cells into CD122-
deficient neonates did not prevent the development of acti-
vated CD69  T cells (Fig. 3 a, bottom middle) and
CD44 CD62L  memory-type T cells (Fig. 3 c, bottom
middle). Transfer of 5   104 CD4 CD25  T cells also did
not alter the abnormal phenotype of CD69  T cells (Fig. 3
a, bottom right) and CD44 CD62L  T cells (Fig. 3 c, bot-
tom right) in CD122-deficient mice, although transfer of a
larger number (2   105) of CD4 CD25  T cells into neo-
nates normalized all the phenotypes in CD122-deficient
mice (not depicted). We also transferred 104 CD8 
CD122  cells obtained from 2-wk-old or 2-yr-old mice
into CD122-deficient neonates. This number of CD8 
CD122  cells from 2-wk-old mice effectively normalized
the shift to activated memory phenotype of T cells in
CD122-deficient mice, whereas the same number of cells
from 2-yr-old mice did not have such activity (Fig. 3,
b and d). These results indicate that at least 104 of
CD8 CD122  cells in young mice are sufficient to per-
form regulatory activity when transferred at neonatal stage,
but the same number of CD8 CD122  cells in older mice
does not contain a sufficient number of regulatory T cells.
We analyzed CD4  T cells and CD8  T cells separately,
and Fig. 3 shows representative results of CD122-deficient
CD4  T cells. Activation and memory status of CD122-
Figure 3. CD122-deficient mice that had received CD8 CD122  T cells at neonatal stage do not develop activated memory-type T cells. (a) After 7
wk from the transfer of 5   104 of indicated T cell subpopulations into CD122-deficient neonates, spleen cells obtained from the mice were stained with
anti-CD69, anti-CD4, and anti-CD45.1 antibodies, and analyzed by flow cytometry. Expression levels of CD69 are shown as histograms for cells gated
to CD4 CD45.1  population. Numbers in each panel are percentages of CD69  cells in gated CD4  cells. Data obtained from a 7-wk-old wild-type
(WT) mouse and a 7-wk-old CD122-deficient mouse (KO) are also shown as controls. (b) Percentages of CD69  cells in gated CD4  cells. Data are
mean   SD values of three mice in each group. Data obtained from CD122-deficient mice that received 104 CD8 CD122  cells obtained from 2-wk-
old mice or 2-yr-old mice are also shown. (c) After 7 wk from the transfer of 5   104 of indicated T cell subpopulations, spleen cells were stained with
anti-CD44, anti-CD62L, anti-CD45.1, and anti-CD4 antibodies, and analyzed by flow cytometry. Data are shown as dot-plot analysis for cells gated to
CD4 CD45.1  population. Numbers in each panel are percentages of naive-type CD44 CD62L  cells in gated CD4  cells. Data obtained from a 7-wk-
old wild-type (WT) mouse and a 7-wk-old CD122-deficient mouse (KO) are also shown as controls. (d) Percentages of naive-type CD44 CD62L  cells
in gated CD4  cells. Data are mean   SD values of three mice in each group. Data obtained from CD122-deficient mice that received 104
CD8 CD122  cells obtained from 2-wk-old mice or 2 yr-old mice are also shown.Rifa’i et al. 1127
deficient CD8  T cells analyzed by expression of CD69,
CD44, and CD62L were not different from those of CD4 
T cells (unpublished data).
CD8 CD122  Cells Normalize Granulocytes, B Cells,
and Erythrocytes in CD122-deficient Mice.  Examination of
granulopoiesis showed that the number of Gr-1  cells in
the bone marrow was markedly increased in CD122-defi-
cient mice (Fig. 4 a, top middle). This increase was normal-
ized by transferring 5   104 CD8 CD122  cells into neo-
nates, but not by transferring 5   104 CD8 CD122  cells
or 5   104 CD4 CD25  T cells (Fig. 4 a, bottom).
Changes in the number of Gr-1  cells in the bone mar-
row  matched those of leukocyte numbers in peripheral
blood. Increased leukocyte number in peripheral blood of
CD122-deficient mice was normalized by the transfer of
5   104 CD8 CD122  cells into neonates but neither by
the transfer of 5   104 CD8 CD122  cells nor by that of
5    104 CD4 CD25  cells (Fig. 4 b). Transfer of 104
CD8 CD122  cells from 2-wk-old mice normalized the
number of Gr-1  cells in the bone marrow (not depicted)
and the leukocyte number in peripheral blood in CD122-
deficient mice, but transfer of 104 CD8 CD122  cells
from 2-yr-old mice did not (Fig. 4 b). Severe anemia
caused by a combination of autoimmune hemolysis and
suppression of erythropoiesis is another striking feature of
CD122-deficient mice (12). Examination of erythroid lin-
eage cells by expression of TER-119 antigen (20), an ery-
throid specific marker, showed marked reduction in
the number of TER-119  cells in the bone marrow of
CD122-deficient mice. This erythroid suppression was also
Figure 4. Normalized granulocytes, erythrocytes, and B cells in CD122-deficient mice that had received CD8 CD122  T cells. (a) After 7 wk from
the transfer of 5   104 of indicated T cell subpopulations into CD122-deficient neonates, bone marrow cells obtained from the mice were stained with
anti–Gr-1 and anti-CD45.1 antibodies, and analyzed by flow cytometry. Percentages of Gr-1  cells are shown for cells gated to CD45.1  population.
Data obtained from a 7-wk-old wild-type mouse (WT) and a 7-wk-old CD122-deficient mouse (KO) are also shown as controls. (b) Numbers of white
blood cells in peripheral blood from mice that had received indicated cell populations were counted using cell-counting chamber. Data are mean   SD
values of three or four mice in each group. Data obtained from CD122-deficient mice that received 104 CD8 CD122  cells obtained from 2-wk-old
mice or 2-yr-old mice are also shown. (c) After 7 wk from the transfer of 5   104 of indicated T cell subpopulations into CD122-deficient neonates,
bone marrow cells obtained from the mice were stained with anti-CD45.1, anti-B220, and anti–TER-119 antibodies, and analyzed by flow cytometry.
Data are shown as dot-plot analysis for cells gated to CD45.1  population. Numbers in each panel are percentages of erythroid lineage cells (TER-119 )
and B lineage cells (B220 ) in CD45.1  bone marrow cells. Data obtained from a 7-wk-old wild-type (WT) mouse and a 7-wk-old CD122-deficient
mouse (KO) are also shown as controls. (d) Hematocrit values of mice that had received the indicated cell populations. Data are mean   SD values of
three or four mice in each group. Data obtained from CD122-deficient mice that received 104 CD8 CD122  cells obtained from 2-wk-old mice or 2-yr-
old mice are also shown.CD8 CD122  Regulatory T Cells Control Other T Cells 1128
rescued by the transfer of 5   104 CD8 CD122  cells into
neonates, whereas the transfer of 5   104 CD8 CD122 
cells or 5   104 CD4 CD25  cells was ineffective, result-
ing in the same decrease of TER-119  cells as that in non-
treated CD122-deficient mice (Fig. 4 c). Analysis of hema-
tocrit in peripheral blood also confirmed the prevention of
anemia by the transfer of CD8 CD122  cells but not by
that of other cell populations (Fig. 4 d). The number of
B220  cells, representing all developing B cells, was also
normalized by the transfer of 5   104 CD8 CD122  cells,
but not by that of 5   104 CD8 CD122  cells or 5   104
CD4 CD25  cells (Fig. 4 c). Again, transfer of 104
CD8 CD122  cells from 2-wk-old mice rescued erythro-
poiesis in the bone marrow (not depicted) and normalized
hematocrit in CD122-deficient mice, whereas transfer of
104 CD8 CD122  cells from 2-yr-old mice did not (Fig. 4
d). As a conclusive result, CD122-deficient mice that re-
ceived CD8 CD122  cells at neonatal period grew nor-
mally and remained healthy. No improvement of general
condition was observed in mice that received 5   104
CD8 CD122  or 5   104 CD4 CD25  cells, and they all
died before 3 mo of age. Transfer of a smaller number (104)
of CD8 CD122  cells from 2-wk-old mice at the neonatal
stage effectively normalized all phenotypes in CD122-defi-
cient mice, but that of the same number of CD8 CD122 
cells from 2-yr-old mice did not. 104 CD4 CD25  cells
obtained from 2-wk-old mice were also ineffective in nor-
malizing CD122-deficient mice (unpublished data).
CD8 CD122  Cells Control Both CD8  and CD4 
Cells. From the aforementioned experimental results, it is
clear that CD8 CD122  cells control CD122-deficient T
cells. To elucidate whether CD8 CD122  cells can con-
trol already-activated T cells, we transferred a mixture of
CD8 CD122  cells and already-activated T cells obtained
from CD122-deficient mice into RAG-2    mice and
analyzed the status of T cells 1 wk later. Activated mem-
ory-type cells (CD44 CD62L ) were dominant among
CD8  and CD4  T cells from CD122-deficient mice
(Fig. 5, a and c, before). After 1 wk of coexistence with
CD8 CD122  cells, naive-type cells (CD44 CD62L )
Figure 5. Effects of CD8 CD122  T cells on CD8  and CD4  T cells. (a) CD8 CD122  T cells and CD8 CD122  T cells were isolated from
C57BL/6CD45.1/CD45.1 congeneic mice by cell sorting. The isolated cells (5   105) were mixed with T cells from CD122-deficient mice (5   106) and
transferred into RAG-2    mice. The status of CD8  T cells from CD122-deficient mice before transfer is shown (left). 1 wk later, spleen cells were har-
vested and examined according to the cell surface marker expression of CD44 and CD62L. Cells that had been cotransferred with CD8 CD122  T cells
( CD8 CD122 ) and those cotransferred with CD8 CD122  T cells ( CD8 CD122 ) were analyzed. Cells gated to CD122-deficient mice–derived
CD8  T cells (CD45.1 CD8 ) are shown. (b) Mean   SD of absolute numbers of naive-type (CD44 CD62L ) and activated-type (CD44 ) CD8  T
cells derived from CD122-deficient mice (CD45.1 CD8 ) before transfer (before) and 1 wk after cotransfer with CD8 CD122  T cells ( CD122 ) or
cotransfer with CD8 CD122  T cells ( CD122 ) (n   5 each). (c) Cell transfer into RAG-2    mice was performed as in a, and analyzed for cells gated
to CD122-deficient mice–derived CD4  T cells (CD45.1 CD4 ). (d) Mean   SD of absolute numbers of naive-type (CD44 CD62L ) and activated-
type (CD44 ) CD4  T cells derived from CD122-deficient mice (CD45.1 CD4 ) for the same groups defined in b. (e) CFSE-labeled CD122    T cells
(5   106) were mixed with CD8 CD122  T cells or CD8 CD122  T cells and transferred into RAG-2    host mice as in a. Dilution of CFSE was
analyzed at 1 wk after adoptive transfer ( CD8 CD122  and  CD8 CD122 ). Data of CFSE-labeled CD122    T cells before transfer are shown as
control (before).Rifa’i et al. 1129
became dominant both in CD8  and CD4  cells (Fig. 5, a
and c,  CD8 CD122 ). In contrast, coexistence with
CD8 CD122  cells did not alter the ratio between naive-
type and activated memory-type cells (Fig. 5, a and c,
 CD8 CD122 ). The absolute number of naive-type
cells increased, but that of activated-type cells rather de-
creased when CD8  and CD4  T cells coexisted with
CD8 CD122  cells (Fig. 5, b and d). CD122-deficient T
cells that had been labeled with CFSE and coexisted
with CD8 CD122  cells for 7 d showed the same pattern
of CFSE intensity as those that had coexisted with
CD8 CD122  cells (Fig. 5 e), indicating that naive-type
cells that appeared after coexistence with CD8 CD122 
cells were not the cells expanded from small number of na-
ive-type cells or stem cells. These results (Fig. 5, b, d, and
e) may better explain the phenomenon observed in Fig. 5
(a and c) as the phenotypic change of cells from activated
type to naive type than by simple expansion of naive cells
or deletion of activated cells. Although the only action to
the CD122-deficient mice–derived T cells has been dem-
onstrated eventually, these results suggest that CD8 CD122 
cells control already-activated T cells of both CD8  and
CD4  types.
Next, we investigated the in vitro action of CD8 
CD122  cells. Wild-type mice–derived CD8 CD122 
cells cocultured with CD8 CD122  cells showed lower
expression of IFN-  than those cultured alone (Fig. 6 a).
Wild-type mice–derived CD4 CD25  cells cocultured
with CD8 CD122  cells also showed low expression of
IFN-  (Fig. 6 b) and IL-2 (not depicted), suggesting that
CD8 CD122  cells can potentially suppress cytokine
expression in both CD8  and CD4  cells derived from
wild-type mice. Time-course study of IFN-  expression
indicated that IFN-  expression was induced in a time-
dependent manner in CD8 CD122  cells cultured alone
with plate-bound anti-CD3 and rIL-2, whereas that in
CD8 CD122  cells cocultured with CD8 CD122  cells
was clearly suppressed through the culture during 2–5 d
Figure 6. (a) Purified CD8 
CD122  T cells (CD45.1, 4  
104) and CD8 CD122  T cells
(CD45.2, 104) were cocultured
in 96-well plates coated with
anti-CD3 antibody for 72 h in a
medium containing rIL-2 (25 U
ml 1). After culture, cells were
stained with anti-CD8 and anti-
CD45.1 antibodies and subjected
to intracellular cytokine staining.
Simple culture of CD8 CD122 
T cells alone (5   104) under the
same condition as coculture was
set as a control (CD8 CD122 ).
Cells gated to CD45.1  region
are shown. Percentage of cells
positively stained with intracellu-
lar IFN-  is presented in the
panels. (b) Purified CD4 CD25 
T cells (CD45.1, 4   104) and
CD8 CD122  T cells (CD45.2,
104) were cocultured and ana-
lyzed as in a, except that anti-
CD4 antibody was used instead
of anti-CD8 antibody. Simple
culture of CD4 CD25  T cells
alone (5   104) was set as a con-
trol (CD4 CD25 ). Cells gated
to CD45.1  region are shown.
Percentages of cells positively
stained with intracellular IFN- 
are presented in the panels. (c) Pu-
rified CD8 CD122  T cells were
cultured alone or cocultured with
CD8 CD122  T cells as in a for
the indicated time intervals, and their IFN-  expression was measured. Percentages of IFN- –expressing cells determined by FACS analysis as shown in
a are presented. (d) CD8 CD122  T cells (2   105) were isolated from OT-I transgenic mice and stimulated with OVA peptide 257-264 (100  g/ml)
plus 2   105 T cell–depleted and  -irradiated (30 Gy) spleen cells in 96-well flat-bottom plates for 48 h. Next, 5   104 of CD8 CD122  or
CD8 CD122  T cells isolated from C57BL/6-CD45.1 mice were added to each well, and the culture was continued for 48 h. Expression of IFN-  on
OT-I transgenic T cells was assessed by intracellular cytokine staining and analyzed by flow cytometry. Data are averages of three independent experi-
ments   SD. (e) OVA-specific Th1 clones, 35-8H or 35-9D (5   104 each) were cocultured with CD8 CD122  T cells or CD8 CD122  T cells (5  
104 each) under stimulation with OVA peptide presented on syngeneic APCs (C57BL/6 spleen cells). IL-2 production was assayed by intracellular cyto-
kine staining after 72 h of culture. Percentages of Th1 clone cells expressing IL-2 are shown. (f) Purified CD8 CD122  T cells (4   104) were labeled with
CFSE and cocultured with CD8 CD122  T cells (104) in 96-well plates coated with anti-CD3 antibody for 48 h without the addition of exogenous IL-2.
After culture, cells were analyzed for their content of CFSE. Simple culture of CFSE-labeled CD8 CD122  T cells alone (5   104) under the same con-
dition as coculture was set as a control (CD8 CD122 ). Percentage of cells that have proliferated is presented in the panels.CD8 CD122  Regulatory T Cells Control Other T Cells 1130
(Fig. 6 c). In this in vitro experiment, only purified
CD8  and CD4  T cells were used and no APCs were
added to the culture. When purified CD8 CD122  cells
from OT-I transgenic mice that express OVA-specific
TCR were stimulated with OVA peptide presented by
MHC class I H-2Kb on syngeneic APCs for 4 d and cocul-
tured with CD45.1-congenic CD8 CD122  T cells dur-
ing the latter 2 d of culture, CD8 CD122  T cells ob-
tained from C57BL/6-CD45.1 mice suppressed IFN- 
production from transgenic T cells (Fig. 6 d). In addition,
CD8 CD122  cells suppressed IL-2 production from
Th1-type clones that were stimulated with antigen and
OVA presented by MHC class II I-Ab on syngeneic APCs
(Fig. 6 e). In these cases, using OVA peptide–responding T
cells, CD8 CD122  cells were not stimulated with anti-
CD3 antibody, indicating that nonspecific activation
was unnecessary for performing the regulatory action in
CD8 CD122  cells. We also examined the activity of
CD8 CD122  cells in suppressing proliferation of regu-
lated cells. The results showed that CD8 CD122  cells
suppressed the proliferation of anti-CD3–stimulated CD8 
CD122  cells when these cells were cocultured without
exogenous IL-2 (Fig. 6 f). This suppression of proliferation
could be due to reduced production of IL-2 from regulated
cells or to direct suppression effect on cell proliferation.
The cytotoxic activity of CD8 CD122  cells against anti-
CD3–activated CD8 CD122  cells or CD4 CD25  in a
culture condition, similar to that used for detecting sup-
pression of cytokine production, was not detected (unpub-
lished data), suggesting that cytotoxic activity against the
regulated cell is not involved in the regulatory action of
CD8 CD122  cells.
Normal CD8 CD122  Cells without CD8 CD122  Cells
Cause Death of RAG-2    Mice.  As the aforementioned
in vitro experiment suggested a regulatory activity of CD8 
CD122  cells to normal T cells, we examined whether
CD8 CD122  cells control normal T cells and how nor-
mal T cells behave in the absence of CD8 CD122  cells
in vivo. The CD8  cell population of normal 6-wk-old
C57BL/6 mice consists of  10% CD122  cells and 90%
CD122  cells (Fig. 7 a). We collected CD8 CD122  cells
and total CD8  cells, each with a purity of  99%, by cell
sorting and transferred 5   105 of these cells into lympho-
cyte-deficient RAG-2    host mice (Fig. 7 a). Surprisingly,
all mice that received CD8 CD122  cells died within 10
wk after cell transfer, whereas all mice that received total
CD8  cells were alive and healthy for  20 wk after cell
transfer (Fig. 7 b).
Normal CD8 CD122  Cells Become Highly Activated
Cells in the Absence of CD8 CD122  Cells.  We exam-
ined the mice at 7 wk after cell transfer into RAG-2   
mice. All tissue of mice that had received CD8 CD122 
cells appeared pale and anemic. Total cell numbers in the
spleen and bone marrow of bilateral femurs of mice that re-
ceived total CD8  cells were not significantly different
from those that received CD8 CD122  cells (spleen:
1.83   0.08   107 vs. 1.64   0.26   107; bone marrow:
5.01   0.25   107 vs. 4.80   0.28   107, respectively,
n   5 each, mean   SD). We analyzed the status of trans-
ferred CD8  cells. Although the numbers of CD8  cells
recovered from spleens were not different between the two
groups (Fig. 8 a), the percentage of activated CD69  cells
was higher in CD8 CD122  cell transfer than in total
CD8  cell transfer (Fig. 8 b). We also transferred 5   105
CD8 CD122  cells mixed with 5   104 CD8 CD122 
cells or 5   103 CD8 CD122  cells into RAG-2    mice.
In the case of transfer of CD8 CD122  cells mixed with
1/10 the number (5   104) of CD8 CD122  cells, the
pattern of total CD8  cell number and the percentage of
CD69  cells in the spleen were similar to those in total
CD8  cell transfer (Fig. 8, a and b). In contrast, the pattern
of total CD8  cell number and the percentage of CD69 
cells in spleen were similar to those in CD8 CD122  cell
transfer in the case of transfer of CD8 CD122  cells mixed
with 1/100 number (5   103) of CD8 CD122  cells. The
activated cells that had originally been CD122  became
CD122  (Fig. 8 c). In the bone marrow, the difference be-
tween CD8 CD122  cell transfer and total CD8  cell
transfer was more evident. The number of CD8  T cells in
Figure 7. Lethal effect of CD8 CD122  T cells transferred into RAG-
2    mice. (a) Spleen cells from a 6-wk-old C57BL/6 mouse were
stained with anti-CD8 and anti-CD122 antibodies, and analyzed by flow
cytometry (left). Rectangle frames represent the regions to collect the de-
sired cells by cell sorting. Collected cells by cell sorting were reanalyzed
by flow cytometry and their purities were confirmed (right). 5   105 of
such purified T cells were injected into each RAG-2    mouse. (b) Sur-
vival of RAG-2    mice that received either CD8 CD122  T cells or
total CD8  cells was monitored for 20 wk (n   17 each). All surviving
mice that received total CD8  cells showed no signs of any illness at 20
wk after transfer.Rifa’i et al. 1131
the bone marrow of CD8 CD122  cell-transferred mice
was  20 times greater than that of total CD8  cell-trans-
ferred mice (Fig. 8 d). The CD8  cells in the bone marrow
of CD8 CD122  cell-transferred mice expressed high lev-
els of the activation marker, CD69 (Fig. 8 e), which was
higher than that of T cells in spleens of the same mice (Fig.
8, b and e). Again, the total CD8  cell number and the ex-
pression pattern of CD69 in the bone marrow of mice that
received 5   105 CD8 CD122  cells mixed with 5   104
CD8 CD122  cells was similar to that in total CD8  cell-
transferred mice, whereas that in the bone marrow of
mice  that received 5   105 CD8 CD122  cells mixed
with 5   103 CD8 CD122  cells was similar to that in
CD8 CD122  cell-transferred mice (Fig. 8, d and e).
Real-time RT-PCR analysis showed higher expression
levels of IFN-  and TNF-  in T cells from CD8 CD122 
cell-transferred mice than those in total CD8  cell-trans-
ferred mice (Fig. 8 f). These features of T cells in CD8 
CD122  cell-transferred mice were similar to those in
CD122-deficient mice, except that the absolute numbers of
T cells in lymph nodes and spleens of the former mice were
smaller than those of the latter mice.
Hematopoietic Disorders in CD8 CD122  Cell-transferred
Mice.  The percentage of granulocytic Gr-1  cells was in-
creased to  90% in the bone marrow of CD8 CD122 
cell-transferred mice compared with  60% in total CD8 
cell-transferred mice (Fig. 9 a). Alternately, cells in ery-
throid lineage that expressed TER-119 almost disappeared
in CD8 CD122  cell transfer (Fig. 9 a). Most of the TER-
119  cells in the bone marrow were VLA4  erythroblasts
Figure 8. Highly activated T cells infiltrate the bone marrow in RAG-2    mice that received CD8 CD122  T cells. (a) Absolute number of CD8 
T cells in spleen was measured at 7 wk after transfer of 5   105 total CD8  T cells, 5   105 CD8 CD122  T cells, 5   105 CD8 CD122  T cells
mixed with 5   104 CD8 CD122  T cells, or 5   105 CD8 CD122  T cells mixed with 5   103 CD8 CD122  T cells into RAG-2    mice. Data
are mean   SD of three to six mice per group. There were no significant differences among the groups (P   0.5). (b) Expression of CD69 on CD8  T
cells in the spleen. Histogram analysis gated to CD8  cells and percentages of CD69  cells in total CD8  cells are shown. (c) Expression of CD122 in
originally CD8 CD122  T cells after transfer into RAG-2    mice. Spleen cells were harvested from a CD8 CD122  T cell–transferred RAG-2   
mouse at 1 wk after transfer and analyzed by staining with indicated antibodies and flow cytometry. Only cells gated to CD8  region are shown, and the
percentage of CD122  cells in total CD8  cells is shown. (d) Absolute number of CD8  T cells in bilateral femoral bone marrow measured at 7 wk after
transfer of CD8 CD122  T cells into RAG-2    mice (n   6) was significantly higher than that in mice that received total CD8  T cells (P   10 5).
Data are mean   SD. The absolute number of CD8  T cells in bone marrow after transfer of 5   105 CD8 CD122  cells mixed with 5   104
CD8 CD122  cells (n   3) was not significantly higher (P   0.5), but that after transfer of 5   105 CD8 CD122  cells mixed with 5   103
CD8 CD122  cells (n   3) was significantly higher than that in mice that received total CD8  T cells (P   10 5). (e) Expression of CD69 on CD8  T
cells in bone marrow. Histogram analysis gated to CD8  cells and percentages of CD69  cells in total CD8  cells. (f) RNA samples were isolated from
CD8  cells recovered from mice that had received either total CD8  T cells or CD8 CD122  T cells and subjected to real-time RT-PCR analysis.
Normalized value for IFN-  or TNF-  mRNA expression in each sample was calculated as the relative quantity of IFN-  or TNF-  divided by the rel-
ative quantity of HPRT. All samples were performed in triplicate. Data are mean   SD.CD8 CD122  Regulatory T Cells Control Other T Cells 1132
(Fig. 9 a, bottom). These bone marrow changes matched
changes in the numbers of red and white blood cells in pe-
ripheral blood. The number of leukocytes was markedly
increased (Fig. 9 b), and hematocrit was significantly re-
duced (Fig. 9 c) in CD8 CD122  cell-recipient mice, in-
dicating progression of anemia in these mice. RAG-2   
mice that had received 5   105 CD8 CD122  cells mixed
with 5   104 CD8 CD122  cells had a normal TER-
119 /Gr-1  cell ratio in the bone marrow (26% of TER-
119  cells and 62% Gr-1 cells; not depicted), normal leu-
kocyte number in peripheral blood (Fig. 9 b), and normal
hematocrit (Fig. 9 c). In contrast, RAG-2    mice that had
received 5   105 CD8 CD122  cells mixed with 5   103
CD8 CD122  cells had a TER-119 /Gr-1  cell ratio
skewed toward Gr-1  cells (2% of TER-119  cells and 91%
of Gr-1  cells; not depicted), increased leukocyte number
in peripheral blood (Fig. 9 b), and low hematocrit (Fig. 9 c).
Discussion
Regulatory T cells are classified into two groups; i.e.,
naturally occurring regulatory cells and regulatory cells in-
duced during immune responses (5). A representative ex-
ample of the former type is in the CD4 CD25  popula-
tion. In this paper, we clearly demonstrated that CD8 
cells contain regulatory T cells reminiscent of naturally oc-
curring type, and that such regulatory cells are relatively
rich in CD8 CD122  population, but are rare in the
CD8 CD122  population.
In recent studies by Malek et al. (21, 22), the defect of
CD4 CD25  regulatory T cells was proposed to be re-
sponsible for the increase of deregulated T cells in CD122-
deficient mice. Based on the fact of the presence of very
few CD4 CD25  T cells in CD122-deficient mice, this
idea might well explain the development of abnormalities
in CD122-deficient mice. However, in the present paper,
transfer of highly purified CD4 CD25  cells failed to res-
cue the phenotypes in CD122-deficient mice (Figs. 3 and
4). These experimental results were incompatible with
those of Malek et al. (21). In their work, CD122-deficient
mice in which CD4 CD25  T cell population had been
transferred at neonatal stage were rescued from the devel-
opment of abnormal phenotypes. There are several possi-
bilities to explain the different results of the two papers. In
our experiment, the number of effective CD4 CD25 
regulatory cells transferred by subcutaneous injection of
5   104 cells might not be sufficient to induce regulatory
activity. Actually, transfer of a higher number (2   105) of
CD4 CD25  in our experiment was effective in normaliz-
ing all the phenotypes in CD122-deficient mice. Thus, the
regulatory activity of CD4 CD25  cells for CD122-defi-
cient T cells was also confirmed in our paper. However, ef-
fective normalization of CD122-deficient mice by transfer
of CD8 CD122  cells but not by that of the same number
of CD4 CD25  cells under the same experimental condi-
tion (Figs. 3 and 4) allows us to make a definite conclusion
that CD8 CD122  cells contain stronger regulatory T cells
that can control CD122-deficient T cells compared with
CD4 CD25  cells.
The CD8 CD122  regulatory cells are exclusively im-
portant in the control of CD8 CD122  cells. CD4 
CD25  regulatory cells do not seem to control normal
CD8 CD122  cells similar to CD8 CD122  cells because
transfer of a mixture of CD4 CD25  cells (105) and wild-
type mice–derived CD8 CD122  cells (4   105) into
RAG-2    mice resulted in the same lethal phenotype as
that of simple CD8 CD122  cells (5   105; unpublished
Figure 9. Increased granulopoiesis and reduced erythropoiesis in
RAG-2    mice that received CD8 CD122  T cells. (a) Bone marrow
cells obtained from RAG-2    mice that had received either total CD8 
cells or CD8 CD122  T cells were stained with anti–Gr-1 and anti–
TER-119 antibodies (top). Percentages of cells in myeloid lineage
(Gr-1 TER-119 ) and cells in erythroid lineage (Gr-1 TER-119 ) are
shown. The same cells were stained with anti–VLA-4 and anti–TER-119
antibodies (bottom). (b) Numbers of leukocytes in peripheral blood of
wild-type (WT) mice and RAG-2    mice that had received 5   105
total CD8  T cells, 5   105 CD8 CD122  T cells, 5   105
CD8 CD122  T cells mixed with 5   104 CD8 CD122  T cells, or
5   105 CD8 CD122  T cells mixed with 5   103 CD8 CD122  T
cells were counted using cell-counting chamber. Data are mean   SD of
three to six mice in each group. (c) Hematocrit values of wild-type (WT)
mice and RAG-2    mice that had received the indicated cell population.
Data are mean   SD of three to six mice in each group.Rifa’i et al. 1133
data). A mixture of one tenth the number (5   104 vs. 5  
105) of CD8 CD122  cells in CD8 CD122  cells pre-
vented the development of lethal phenotype caused by de-
regulated activation of CD8  T cells, whereas a mixture of
one hundredth the number (5   103 vs. 5   105) of
CD8 CD122  cells in CD8 CD122  cells did not (Figs. 8
and 9), indicating that CD8 CD122  cells ranging from
one hundredth to one tenth of the number of CD8 
CD122  cells are necessary to maintain homeostasis in acti-
vation of CD8  T cells. CD8 CD122  T cells, along
with CD8 CD122  cells, do not express Foxp3 (unpub-
lished data), also suggesting that CD8 CD122  cells are dif-
ferent cell lineage from CD4 CD25  cells. Although the
precise mechanism of regulation by CD8 CD122  cells is
not clear at present, the experimental results of in vitro co-
cultures (Fig. 6, a–c) suggest a direct interaction between
the regulatory cells and regulated cells without intervention
of APCs. This feature is different from that of CD4 CD25 
regulatory T cells, which require the interposition of APCs
for regulatory action (23–25). Another exclusive feature of
CD8 CD122  cells may be that they possibly change the
character of already-activated T cells, at least in case of
CD122-deficient mice–derived T cells (Fig. 5, a–d).
Apart from the aforementioned difference between
CD4 CD25  regulatory T cells and CD8 CD122  cells, it
is quite an interesting correlation that CD25 (IL-2 receptor
  chain) and CD122 (IL-2 receptor   chain) could be
markers for regulatory T cells in CD4  populations and
CD8  populations, respectively. IL-2 seems to be essential
for maintaining already-developed CD4 CD25  regulatory
T cells (21). For the development of CD4 CD25  cells, IL-2
receptor   chain is not essential because CD122-deficient
mice that were cured by inoculating CD8 CD122  regula-
tory T cells at neonate developed CD4 CD25  cells that
were not genetically affected (unpublished data). Alter-
nately, IL-2 receptor   chain may be rather required in the
development of CD8 CD122  regulatory T cells in the
thymus because the exogenous expression of CD122 only
in the thymus is sufficient to normalize the phenotype of
CD122-deficient mice (21). IL-2 does not seem to be indis-
pensable for the development of CD8 CD122  regulatory
T cells because IL-2–deficient mice do possess CD8 
CD122  cells (unpublished data) that could possibly be
maintained by the compensatory action of other cytokines,
including IL-15. The CD8 CD122  regulatory T cells
cannot be induced from CD8 CD122  cells even if they
restored the expression of CD122 molecule. Actually, some
CD8 CD122  cells transferred into CD122-deficient neo-
nates (unpublished data) or into RAG-2    mice (Fig. 7 c)
become CD122 , suggesting that expression of CD122
molecule is not sufficient to provide regulatory activity.
In the same way that CD25 (which is also expressed in
activated T cells) is not an exclusive marker for CD4  reg-
ulatory T cells, CD122 cannot be an ideal marker for
CD8  regulatory T cells. CD8 CD122  populations have
been considered memory-type T cells and their number
actually increases in old mice. The recently identified sub-
populations of memory T cells called “central memory T
cells” have a cell surface marker of CD8 CD122 CD62L 
(26–32). Alternately, CD8 CD122  cells, which also ex-
press CD62L, are relatively abundant in neonatal mice
( 50% of total CD8  in 1-wk-old mice; Fig. 1 b). The
change in percentage of CD8 CD122  cells in CD8  cells,
which show two age-related phases (Fig. 1 b), may suggest
two different components in this population. As the number
of memory T cells is increased in older mice, the increased
ratio of CD8 CD122  cells at old age may be due to the
increase of central memory T cells (29, 30, 33). Instead, a
higher rate of regulatory T cells may contribute to the high
ratio of CD8 CD122  cells in younger mice. Thus, the
CD8 CD122  population may include both the regulatory
T cells and the central memory T cells. These results em-
phasize the need for markers that distinguish CD8 CD122 
regulatory T cells from the central memory T cells.
We noted extreme activation of CD8  cells in RAG-2   
mice that received CD8 CD122  cells. How such acti-
vated T cells are generated and which antigens they are re-
sponding to remain unclear at present. The profile of TCR
V  usage of activated CD8  T cells in CD8 CD122  cell-
transferred mice was not significantly different from that of
nonactivated T cells in total CD8  cell-transferred mice
(unpublished data), suggesting that the activated T cells
were polyclonal cells responding to multiple antigens. Sim-
ilar activation of T cells was observed in CD122-deficient
mice, in which the activated T cells were also polyclonal
(13), further supporting polyclonal activation of CD8  T
cells in CD8 CD122  cell-transferred mice. The activated
T cells in CD8 CD122  cell-transferred mice, and possi-
bly those in CD122-deficient mice as well, could be re-
sponding to multiple self-antigens, foreign antigens, or
both. Whatever the antigens are, activated T cells may dis-
appear in a usual condition with CD8 CD122  regulatory
cells but remain without such regulatory cells (Fig. 5, a–d).
In this paper, we demonstrated that the regulatory cells
that control CD122  T cells are in the CD8 CD122 
population, but not in the CD8 CD122  population. We
propose here that CD8 CD122  T cells include a new
type of regulatory T cells that effectively regulates other T
cells. Normal CD8 CD122  T cells become dangerously
activated cells that cause lethality unless the regulatory T
cells in CD8 CD122  population properly regulate them.
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